|
A site reported to rxsight that a patient's light adjustable lens+ (lal+) was explanted from the left eye (os) due to blurred vision and changes in manifest refraction (mr) secondary to suspected photopolymerization.The patient had completed two light treatments an no lock-in treatments before presenting to clinic one year later, complaining of blurry vision os.Slit lamp examination revealed a small central bulge on the lal+.Additionally, the patient reported not wearing rxsight uv protective eyewear while swimming.The lal+ was explanted and replaced with another lal+ without complications.
|
|
Per the instructions for use (ifu), use of the lal is contraindicated in cases where: "the patient is unwilling to comply with the postoperative regimen for adjustment and lock-in treatments and wearing of uv protective eyewear." additionally, "seventeen (17) to 24 days after surgery, the patient is to return for examination and a 1st adjustment treatment.Subsequent second and third adjustment treatments, if necessary, are all separated by 3-7 days.The patient will receive the 1st lock-in treatment 3-7 days after the final adjustment treatment.If necessary, lock-in #2 may be performed 3-7 days after lock-in #1."
manufacturing records were reviewed and found no deviations, non-conformance, or other manufacturing issues related to the reported event.The product was received by the manufacturer and is pending investigation.Manufacturer reference#: (b)(4).
|